title: The production and evaluation of a radioligand and antiserum for the radioimmunoassay of subnanogram per millilitre concentrations of lamivudine.
authors.affiliation: Division of Drug Metabolism, Glaxo Research and Development, Ware, Hertfordshire, UK.
authors.forename: S A
authors.initials: SA
authors.lastname: Wring
authors.forename: R M
authors.initials: RM
authors.lastname: O'Neill
authors.forename: J L
authors.initials: JL
authors.lastname: Williams
authors.forename: W N
authors.initials: WN
authors.lastname: Jenner
authors.forename: M J
authors.initials: MJ
authors.lastname: Daniel
authors.forename: M R
authors.initials: MR
authors.lastname: Gray
authors.forename: J J
authors.initials: JJ
authors.lastname: Newman
authors.forename: G N
authors.initials: GN
authors.lastname: Wells
authors.forename: D R
authors.initials: DR
authors.lastname: Sutherland
mesh_terms: D000818:Animals; D003429:Cross Reactions; D007106:Immune Sera / Q000096:biosynthesis* / Q000276:immunology; D019259:Lamivudine; D008024:Ligands; D013058:Mass Spectrometry; D009711:Nucleotides / Q000276:immunology; D011863:Radioimmunoassay; D012680:Sensitivity and Specificity; D012756:Sheep; D016047:Zalcitabine / Q000031:analogs & derivatives* / Q000032:analysis / Q000138:chemical synthesis / Q000276:immunology
chemical_list: D007106:Immune Sera; D008024:Ligands; D009711:Nucleotides; D019259:Lamivudine; D016047:Zalcitabine